SILICON LABORATORIES INC.
For the period ended Jan 3, 2026. Filed Feb 10, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Feb 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
Rule 10b5-1 Trading Arrangements
The following table describes contracts, instructions, or written plans for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) entered into or terminated during the quarter ended January 3, 2026 by our directors and officers (as defined under Rule 16b-1(f) of the Exchange Act). There were no non-Rule 10b5-1 trading arrangements entered into orterminated by our directors and officers during the quarter ended January 3, 2026.
| Name and Title of Director or Officer | Date of Adoption of Arrangement | Duration of the Arrangement | Aggregate Number of Securities to be Purchased or Sold Pursuant to the Arrangement |
|---|---|---|---|
| R. Matthew JohnsonPresident & CEO | November 06, 2025 | Expires November 06, 2026 | 24,1931 |
(1)Represents the total number of shares that may be sold under the trading arrangement, which includes shares underlying restricted stock units (“RSUs”) and performance share units (“PSUs”). The actual number of shares sold may be less based on tax withholdings and performance and vesting conditions of the awards.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.